Biotechnology company.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Arcturus Therapeutics Holdings Inc. in the last 30 days yet.
The 1 sources with the most insights about Arcturus Therapeutics Holdings Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
A key cystic fibrosis drug, considered the company's 'big hope,' has failed, which is a significant bearish development as 'that hope is gone'.
A key cystic fibrosis drug, considered the company's 'big hope,' has failed, which is a significant bearish development as 'that hope is gone'.
Other assets that creators frequently mention in the same content as Arcturus Therapeutics Holdings Inc..
The most active sources covering Arcturus Therapeutics Holdings Inc. (ARCT) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Arcturus Therapeutics Holdings Inc. (ARCT) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Arcturus Therapeutics Holdings Inc. (ARCT) most frequently also discuss QBTS, NVDA, OGN, ABVX, IONQ. See the "Discussed alongside" section above for full asset pages.